{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T02:53:01Z","timestamp":1771210381772,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Medical Clinic, University Hospital Heidelberg"},{"name":"Programme of the Medical Faculty of Heidelberg University"},{"name":"Olympia Morata"},{"name":"the National Center for Tumor Diseases, University Hospital Heidelberg"},{"DOI":"10.13039\/501100010564","name":"German Center for Lung Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010564","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1136\/ard-2023-224839","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T17:20:18Z","timestamp":1711992018000},"page":"974-983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease"],"prefix":"10.1016","volume":"83","author":[{"given":"Karolina","family":"Gente","sequence":"first","affiliation":[]},{"given":"Manuel","family":"Feisst","sequence":"additional","affiliation":[]},{"given":"Dorothea","family":"Marx","sequence":"additional","affiliation":[]},{"given":"Karel D","family":"Klika","sequence":"additional","affiliation":[]},{"given":"Petros","family":"Christopoulos","sequence":"additional","affiliation":[]},{"given":"J\u00fcrgen","family":"Graf","sequence":"additional","affiliation":[]},{"given":"Julia","family":"Will","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Luft","sequence":"additional","affiliation":[]},{"given":"Jessica C","family":"Hassel","sequence":"additional","affiliation":[]},{"given":"Carsten","family":"M\u00fcller-Tidow","sequence":"additional","affiliation":[]},{"given":"Rui A","family":"Carvalho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8197-8681","authenticated-orcid":false,"given":"Hanns-Martin","family":"Lorenz","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6923-0590","authenticated-orcid":false,"given":"M Margarida","family":"Souto-Carneiro","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/ard-2023-224839_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.30155","article-title":"The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases","volume":"63","author":"Crowson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-224839_bib2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/bjc.2014.606","article-title":"Trends in the lifetime risk of developing cancer in great Britain: comparison of risk for those born from 1930 to 1960","volume":"112","author":"Ahmad","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1136\/ard-2023-224839_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamaoncol.2021.5680","article-title":"Immune-mediated diseases associated with cancer risks","volume":"8","author":"He","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1136\/ard-2023-224839_bib4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrrheum.2014.138","article-title":"Paraneoplastic syndromes in rheumatology","volume":"10","author":"Manger","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2023-224839_bib5","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4065\/mcp.2010.0099","article-title":"Paraneoplastic syndromes: an approach to diagnosis and treatment","volume":"85","author":"Pelosof","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1136\/ard-2023-224839_bib6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/metabo11090630","article-title":"Metabolomic profiling in lung cancer: a systematic review","volume":"11","author":"Madama","year":"2021","journal-title":"Metabolites"},{"key":"10.1136\/ard-2023-224839_bib7","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.3748\/wjg.v26.i20.2514","article-title":"Metabolomics profile in gastrointestinal cancers: update and future perspectives","volume":"26","author":"Nannini","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1136\/ard-2023-224839_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrrheum.2016.1","article-title":"Metabolomics in rheumatic diseases: desperately seeking biomarkers","volume":"12","author":"Guma","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2023-224839_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/annrheumdis-2019-216374","article-title":"Differences in the serum Metabolome and Lipidome identify potential biomarkers for Seronegative rheumatoid arthritis versus Psoriatic arthritis","volume":"79","author":"Souto-Carneiro","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224839_bib10","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1021\/acs.jproteome.8b00456","article-title":"NMR-based serum metabolomics of patients with Takayasu arteritis: relationship with disease activity","volume":"17","author":"Jain","year":"2018","journal-title":"J Proteome Res"},{"key":"10.1136\/ard-2023-224839_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159384","article-title":"Metabolic profiling of systemic lupus erythematosus and comparison with primary Sjogren's syndrome and systemic sclerosis","volume":"11","author":"Bengtsson","year":"2016","journal-title":"PLoS One"},{"key":"10.1136\/ard-2023-224839_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s12916-022-02700-x","article-title":"Distinct metabolic biomarkers to distinguish Igg4-related disease from Sjogren's syndrome and Pancreatic cancer and predict disease prognosis","volume":"20","author":"Yan","year":"2022","journal-title":"BMC Med"},{"key":"10.1136\/ard-2023-224839_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/cells11030323","article-title":"Saliva metabolomics in dry mouth patients with head and neck cancer or Sjogren's syndrome","volume":"11","author":"Hynne","year":"2022","journal-title":"Cells"},{"key":"10.1136\/ard-2023-224839_bib14","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/ard-2022-222451","article-title":"Distinct immune-Effector and metabolic profile of Cd8(+) T cells in patients with autoimmune Polyarthritis induced by therapy with immune Checkpoint inhibitors","volume":"81","author":"Benesova","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224839_bib15","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20194027","article-title":"A biochemical comparison of the lung, Colonic, brain, renal, and ovarian cancer cell lines using 1H-NMR spectroscopy","volume":"40","author":"Hu","year":"2020","journal-title":"Biosci Rep"},{"key":"10.1136\/ard-2023-224839_bib16","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1038\/s41591-022-01980-3","article-title":"Metabolomic profiles predict individual Multidisease outcomes","volume":"28","author":"Buergel","year":"2022","journal-title":"Nat Med"},{"issue":"Suppl 6","key":"10.1136\/ard-2023-224839_bib17","doi-asserted-by":"crossref","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"51","author":"Kay","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-224839_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fmed.2018.00246","article-title":"Classification and outcome measures for Psoriatic arthritis","volume":"5","author":"Leung","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1136\/ard-2023-224839_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The assessment of Spondyloarthritis International society classification criteria for peripheral Spondyloarthritis and for Spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224839_bib20","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.semarthrit.2019.09.009","article-title":"EULAR\/ACR classification criteria for SLE","volume":"49","author":"Aringer","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2023-224839_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/sim.8779","article-title":"Selection of variables for multivariable models: opportunities and limitations in Quantifying model stability by Resampling","volume":"40","author":"Wallisch","year":"2021","journal-title":"Stat Med"},{"key":"10.1136\/ard-2023-224839_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard-2023-224839_bib23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature06734","article-title":"The M2 splice Isoform of pyruvate kinase is important for cancer metabolism and tumour growth","volume":"452","author":"Christofk","year":"2008","journal-title":"Nature"},{"key":"10.1136\/ard-2023-224839_bib24","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ijc.33877","article-title":"Metabolomics study reveals systematic metabolic dysregulation and early detection markers associated with incident pancreatic cancer","volume":"150","author":"Wang","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1136\/ard-2023-224839_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.trecan.2019.11.009","article-title":"Metabolic fitness and plasticity in cancer progression","volume":"6","author":"McGuirk","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1136\/ard-2023-224839_bib26","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1038\/s41388-020-01639-8","article-title":"The functional roles of TCA cycle metabolites in cancer","volume":"40","author":"Eniafe","year":"2021","journal-title":"Oncogene"},{"key":"10.1136\/ard-2023-224839_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/ard-2022-223626","article-title":"L-arginine metabolism inhibits arthritis and inflammatory bone loss","volume":"83","author":"Cao","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-224839_bib28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41467-020-14285-1","article-title":"Environmental arginine controls multinuclear giant cell metabolism and formation","volume":"11","author":"Brunner","year":"2020","journal-title":"Nat Commun"},{"key":"10.1136\/ard-2023-224839_bib29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/ac00101a004","article-title":"750 Mhz 1H and 1H-13C NMR spectroscopy of human blood plasma","volume":"67","author":"Nicholson","year":"1995","journal-title":"Anal Chem"},{"key":"10.1136\/ard-2023-224839_bib30","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1021\/acs.jproteome.7b00879","article-title":"Optimized Phenotypic biomarker discovery and confounder elimination via covariate-adjusted projection to latent structures from metabolic spectroscopy data","volume":"17","author":"Posma","year":"2018","journal-title":"J Proteome Res"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2023-224839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T08:17:07Z","timestamp":1739521027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0003496724000207"],"URL":"https:\/\/doi.org\/10.1136\/ard-2023-224839","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-224839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 \u00a9 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}